Ed Shenkan is a seasoned healthcare industry professional with expertise in strategic planning, M&A due diligence, valuation analysis, business development, market research, and financial modeling. He completed his Bachelor of Science in Economics and Bachelor of Arts in Anthropology at The Wharton School and his Master of Business Administration at Duke University's Fuqua School of Business. Ed is the founder of Shenkan Advisors, a company that offers advisory services to healthcare company boards, management teams, and investors. Their services include market assessments, company valuations, investment decision-making, strategic planning, and M&A due diligence.

Ed has previously held various positions in the healthcare industry, including Consultant at Shenkan Advisors, Equity Research Analyst at Needham & Company, Equity Research Analyst at Wells Fargo, Associate Analyst at JPMorgan Chase, and District Manager, Marketing, and Business Development Associate at Schering-Plough. He is also a Member of the Board of Directors at GI Scientific, and has authored industry reports on several healthcare niches such as ophthalmology, cardio-vascular, radiation therapy, neurovascular, and spinal related products and companies.